Cefepime/sulbactam combination as a treatment alternative for extended spectrum beta-lacatmase producing Enterobacterales: A multicentric study from India

Background: Piperacillin/tazobactam has limited activity against Enterobacterales, which concurrently express ESBL/ampC/OXA-1 beta-lactamases, which are widely prevalent in India. Thus, there is a severe dearth for carbapenem sparing options that aggravate more dependent carbapenem therapy. In the I...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yamuna Devi Bakthavatchalam, Dhanalakshmi Solaimalai, Anand Ashok, Harthi Ragothaman, Soniya Krishnamoorthy, Nivedhana Subburaju, Sanjay bhattacharya, Rudresh Sm, Shripad Murlidhar Taklikar, Barney Isaac, Kamini Walia, Balaji Veeraraghavan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-07-01
Colecção:	Clinical Epidemiology and Global Health
Assuntos:	Cefepime Sulbactam ESBL OXA-1 Piperacillin/tazobactam Cefoperazone/sulbactam
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S221339842400006X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!